Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 01, 2024 08:30 ET | Source: Palisade Bio, Inc.

Palisade Bio’s Lead Product Candidate, PALI-2108 Demonstrates Potent Anti-Inflammatory Effects in Ex-Vivo Study of Whole Blood Samples Challenged with Pro-Inflammatory Lipopolysaccharide (LPS)

Company on track to commence Phase 1 human clinical study of PALI-2108 for the treatment of Ulcerative Colitis (UC) before year end Carlsbad, CA, May 01, 2024 (GLOBE NEWSWIRE) -- Palisade...
September 08, 2022 11:00 ET | Source: Glasswing Ventures

Glasswing Ventures Raises Oversubscribed $158M Fund II

BOSTON, Sept. 08, 2022 (GLOBE NEWSWIRE) -- Glasswing Ventures, an early-stage venture capital firm investing in the next generation of intelligent enterprise and frontier technology startups, today...
November 15, 2017 09:00 ET | Source: Immuron Limited

Immuron Granted US Patent for NASH Treatment

MELBOURNE, Australia, Nov. 15, 2017 (GLOBE NEWSWIRE) -- Immuron Limited (ASX:IMC) (NASDAQ:IMRN), an Australian microbiome biopharmaceutical company focused on developing and commercialising oral...
May 29, 2013 19:45 ET | Source: WeissLaw LLP

Lender Processing Services, Inc. Acquisition by Fidelity National Financial, Inc. May Not be in the Best Interests of LPS Shareholders

NEW YORK, May 29, 2013 (GLOBE NEWSWIRE) -- The fairness of the proposed acquisition of Lender Processing Services, Inc. ("LPS" or the "Company") by Fidelity National Financial, Inc. ("FNF") is the...
May 17, 2011 11:06 ET | Source: Green Peak Partners

Potential Investors Into Private Equity Funds Feel Ill-Equipped to Evaluate PE Teams -- Even Though "People" Dimension of Managers Is Now of Greater Investor Concern Than Investing Strategy, According to New Survey Results

DENVER, CO--(Marketwire - May 17, 2011) - While investors into Private Equity funds say they feel equipped to assess funds' investment strategies, they say they feel ill-equipped to assess private...